The global steam and hydrogen peroxide biological indicators market size reached USD 725.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,336.3 Million by 2033, exhibiting a growth rate (CAGR) of 6.67% during 2025-2033. The increasing number of hospitals, rising emphasis on infection control practices, and the growing number of surgical procedures represent some of the key factors driving the market.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 725.6 Million |
Market Forecast in 2033
|
USD 1,336.3 Million |
Market Growth Rate 2025-2033 | 6.67% |
Steam biological indicators (BIs) are test systems used to monitor the effectiveness of steam sterilization processes in healthcare facilities, laboratories, and other settings. They consist of a carrier material, such as filter paper or a strip, infused with a standardized population of heat-resistant bacterial spores like Bacillus stearothermophilus or Bacillus subtilis. On the other hand, hydrogen peroxide BIs are utilized to examine the efficiency of sterilization processes that utilize hydrogen peroxide as the sterilizing agent. They are generally used in low-temperature sterilization methods like hydrogen peroxide gas plasma sterilization or vaporized hydrogen peroxide (VHP) sterilization. They serve as a quality control measure to ensure that sterilization processes are consistently achieving the desired level of microbial inactivation.
The increasing number of hospitals, clinics, and other healthcare facilities that require reliable sterilization methods to ensure patient safety represents one of the major factors driving the demand for steam and hydrogen peroxide BIs around the world. Moreover, the rising emphasis on infection control practices is catalyzing the demand for accurate and reliable biological indicators to validate sterilization processes. In addition, the growing usage of steam and hydrogen peroxide BIs in the pharmaceutical industry to maintain the sterility of the products, such as drugs, vaccines, and injectables, is influencing the market positively. Apart from this, healthcare authorities of numerous countries are implementing stringent regulations concerning the sterilization of devices in healthcare facilities worldwide. They are also focusing on maintaining patient safety and deterring the spread of infections. Furthermore, the increasing adoption of steam and hydrogen peroxide BIs in numerous research laboratories and diagnostic labs to avoid cross contamination and control sterile conditions is favoring the growth of the market. Besides this, there is a rise in the number of surgical procedures on account of the increasing prevalence of different chronic ailments. This, coupled with the growing aging population that is more susceptible to developing these diseases, is creating a positive outlook for the market. Additionally, the rising use of steam and hydrogen BIs in different medical equipment, such as reusable hemodialysis machines, respiratory care devices, dental instruments, infusion pumps, and surgical instruments, to prevent pathogen transfer is strengthening the growth of the market.
IMARC Group provides an analysis of the key trends in each segment of the global steam and hydrogen peroxide biological indicators market, along with forecasts at the global, regional, and country levels from 2025-2033. Our report has categorized the market based on product type and application.
Product Type Insights:
The report has provided a detailed breakup and analysis of the steam and hydrogen peroxide biological indicators market based on the product type. This includes self-contained vials, spore strips, and spore-suspension. According to the report, self-contained vials represented the largest segment.
Application Insights:
A detailed breakup and analysis of the steam and hydrogen peroxide biological indicators market based on the application has also been provided in the report. This includes pharmaceutical and medical device companies and healthcare facilities. According to the report, healthcare facilities accounted for the largest market share.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for steam and hydrogen peroxide biological indicators. Some of the factors driving the North America steam and hydrogen peroxide biological indicators market included the expansion of the healthcare industry, product innovations, extensive research and development (R&D) activities, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global steam and hydrogen peroxide biological indicators market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include 3M Company, Bioquell Limited (Ecolab Solution), Etigam, Getinge AB (Carl Bennet AB), GKE Australia, Liofilchem S.r.l., Mesa Laboratories Inc, Steris Corporation, Terragene S. A., Tuttnauer, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Scope of the Report | Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
|
Product Types Covered | Self-Contained Vials, Spore Strips, Spore-Suspension |
Applications Covered | Pharmaceutical and Medical Device Companies, Healthcare Facilities |
Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | 3M Company, Bioquell Limited (Ecolab Solution), Etigam, Getinge AB (Carl Bennet AB), GKE Australia, Liofilchem S.r.l., Mesa Laboratories Inc, Steris Corporation, Terragene S. A., Tuttnauer, etc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |